Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension

Acta Physiologica Hungarica

Volumn 94, Issue 1-2, 2007, Pages 49-66

  Barath A ^a   Endreffy, E ^a   Bereczki, Cs ^a   Gellen B ^a   Szucs B ^a   Nemeth I ^a   Turi S ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adolescent; Body mass index; Essential hypertension; Obesity; Single nucleotide polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; NITROGEN OXIDE; NOS3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD; BODY MASS; CHILD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERTENSION; MALE; OBESITY;

ADOLESCENT; BODY MASS INDEX; CHILD; ENDOTHELIN-1; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE TYPE III; NITROGEN OXIDES; OBESITY; POLYMORPHISM, GENETIC;

EID: 34248136390     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.94.2007.1-2.6     Document Type: Article

References (79)

1. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell (Review) 104(4), 545-556 (2001)
2. MacMahon S, Petro R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335(8692), 765-774 (1990)
3. Stamler J: Epidemic obesity in the United States. Arch. Intern. Med. 153(9), 1040-1044 (1993)
4. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90(1), 583-612 (1994)
5. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988-1991
6. Staessen JA, Wang J, Bianchi G, Birkenhager WH: Essential hypertension. Lancet 361(9369), 1629-1641 (2003)
7. Lifton RP: Molecular genetics of human blood pressure variation. Science (Review) 272(5262), 676-680 (1996)
8. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM: A chimaeric 11 betahydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355(6357), 562-526 (1992)
9. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Finding JW et al.: Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79(3), 407-414 (1994)
10. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP: Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat. Genet. 11(1), 76-82 (1995)
11. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat. Genet. 10(4), 394-399 (1995)
12. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP: Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289(5476), 119-123 (2000)
13. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP: Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat. Genet. 16(2), 202-205 (1997)
14. Morris BJ, Benjafield AV, Lin RC: Essential hypertension: genes and dreams. Clin. Chem. Lab. Med. (Review) 41(7), 834-844 (2003)
15. Kato N: Genetic analysis in human hypertension. Hypertens. Res. (Review) 25(3), 319-327 (2002)
16. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22(3), 231-238 (1999) Erratum in: Nat. Genet. 23(3), 373 (1999)
17. Chakravarti A: Population genetics-making sense out of sequence. Nat. Genet. (Review) 21(1 Suppl), 56-60 (1999)
18. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat. Genet. 22(3), 239-247 (1999)
19. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 113(3 Pt 1), 475-482 (2004)
20. Klumbiene J, Dambraus Kaite-Guadaviciene TV, Zaborskis A, Shatchkute A: Blood pressure tracking from childhood to early adulthood. Medicine 33, 97-112 (1997)
21. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA: Association between multiple risk factors and atherosclerosis in children and young adults. N. Engl. J. Med. 338, 1650-1656 (1998)
22. Klumbiene J, Sileikiene L, Milasauskien Z, Zaborskis A, Shatchkute A: The relationship of childhood to adulthood pressure: Longitudinal study of juvenile hypertension in Lithuania. J. Hypertens. 18, 531-538 (2000)
23. Rocchini AP: Adolescent obesity and hypertension. Pediatric Clin. North Am. 40, 81-92 (1993)
24. Sorof J, Daniels S: Obesity hypertension in children. A problem of epidemic proportions. Hypertension 10, 1161/01 (2002)
25. Flynn JT, Alderman MH: Characteristics of children with primary hypertension seen at a referral center. Pediatr. Nephrol. (7), 961-6 (2005). Epub 2005 Apr 27.
26. Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD: Body mass index in primary and secondary pediatric hypertension. Pediatr. Nephrol. 19(12), 1379-1384 (2004)
27. Reade EP, Whaley C, Lin JJ, McKenney DW, Lee D, Perkin R: Hypopnea in pediatric patients with obesity hypertension. Pediatr. Nephrol. 2004 Sep, 19(9): 1014-1020. Epub. Jun 4 (2004)
28. Nicklas TA, Baranowski T, Cullen KW, Berenson G: Eating patterns, dietary quality and obesity. Journal of the American College of Nutrition. 20, 599-608 (2001)
29. Parsons TJ, Power C, Logan S, Summerbell CD: Childhood predictors of adult obesity: a systematic review. International Journal of Obesity 23, S1-S107 (1999)
30. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH: Predicting obesity in young adulthood from childhood and parental obesity. N. Engl. J. Med. 337, 869-873 (1997)
31. Mossberg HO: 40-year follow-up of overweight children. Lancet 2, 491-493 (1989)
32. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH: Long-term morbidity and mortality of overweight adolescents - a follow-up of the Harvard growth study of 1922 to 1935. N. Engl. J. Med. 327, 1350-1355 (1992)
33. Sorof JM, Poffenbarger T, Franco K, Bernard L, Portman RJ: Isolated systolic hypertension, obesity and hyperkinetic hemodynamic states in children. J. Pediatr. 140, 660-666 (2002)
34. Alpert BS: Exercise in hypertensive children and adolescents: any harm done? Pediatric Cardiol. 20, 66-69 (1999)
35. Nicholas SB: Lipid disorders in obesity. Curr. Hypertens. Resp. 1, 131-136 (1999)
36. de Simone G, Devereux RB, Roman MJ: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23, 600-606 (1994)
37. Ribstein J, Callar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26, 610-615 (1995)
38. Barrett-Connor E, Khaw K: Is hypertension more benign when associated with obesity? Circulation 72, 53-60 (1985)
39. Goldbourt U, Holtzman E, Cohen-Mandelzweig L, Neufeld HN: Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension 10, 22-28 (1987)
40. Carman WJ, Barrett-Connor E, Sowers M, Khaw K: Hypertension/risk factors: higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumesh, Michigan. Circulation 89, 703-711 (1994)
41. Barath A, Turi S, Nemeth I, Bereczki C, Gellen B, Haszon I, Monostori P: Different pathomechanisms of essential and obesity-associated hypertension in adolescents. Pediatr. Nephrol. 21(10), 1419-1425 (2006). Epub 2006 Aug 8.
42. Huxley RR, Shiell AW, Law CM: The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J. Hypertens. 18, 815-831 (2000)
43. Mi J, Law CM, Zhang K-L, Osmond C, Stein CE, Barker DJP: Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann. Intern. Med. 132, 253-260 (2000)
44. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 71(1), 169-180 (1992)
45. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X: Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension (Review) 33(6), 1324-1331 (1999)
46. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E: Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97(18), 1773-1779 (1998)
47. Quyyumi AA: Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am. J. Med. 105 (1A), 32S-39S (1998)
48. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323 (1), 27-36 (1990)
49. Schiffrin EL: State-of-the-art lecture. Role of endothelin-1 in hypertension. Hypertension 34 (4 Pt 2), 876-881 (1999)
50. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348(6303), 730-732 (1990)
51. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348 (6303), 732-735 (1990)
52. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368 (1994) (6473) 703-710
53. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 322(3), 205 (1990)
54. Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am. J. Hypertens. 4 (4 Pt 1), 303-308 (1991)
55. Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, Dargie HJ, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F: The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33(5), 1169-1174 (1999)
56. Treiber FA, Barbeau P, Harshfield G, Kang HS, Pollock DM, Pollock JS, Snieder H: Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity. Hypertension 42(4), 494-499 (2003)
57. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, Araki T, Satoh H, Hisamichi S, Imai Y, Ogihara T: Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 38(6), 1321-1324 (2001)
58. Barden AE, Herbison CE, Beilin LJ, Michael CA, Walters BN, Van Bockxmeer FM: Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J. Hypertens. 19(10), 1775-1782 (2001)
59. Glowinska B, Urban M, Hryniewicz A, Peczynska J, Florys B, Al-Hwish M: Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors. Kardiol. Pol. 61(10), 329-338 (2004)
60. Schmidt HH, Walter U: NO at work. Cell 78(6), 919-925 (1994)
61. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329(27), 2002-2012 (1993)
62. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 272(5 Pt 2), F561-F578 (1997)
63. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Nat. Acad. Sci. USA 87(2), 682-685 (1990)
64. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F: Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 198(3), 1027-1033 (1994)
65. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268(23), 17478-17488 (1993)
66. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K: T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22), 2864-2870 (1999)
67. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377(6546), 239-242 (1995)
68. Haynes WG, Noon JP, Walker BR, Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertens. 12, 1375-1380 (1993)
69. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N: Basal nitric oxide synthesis in essential hypertension. Lancet 349(9055), 837-842 (1997)
70. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teroaka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32, 3-8 (1998)
71. Kajiyama N, Saito Y, Miyamoto Y, Yoshimura M, Nakayama M, Harada M, Kuwahara K, Kishimoto I, Yasue H, Nakao K: Lack of association between T-786->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens. Res. 6, 561-555 (2000)
72. Zanchi DK, Moczulski L, Hanna S, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57(2), 405-413 (2000)
73. Wang J, Dudley D, Wang XL: Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler. Thromb. Vasc. Biol. 22(5), 1-4 (2002)
74. Soergel M, Kirschtein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W: Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J. Pediatr. 130(2), 178-184 1(997)
75. Brewer ED, Avner ED, Harmon WE, Niaudet P: Evaluation of hypertension in childhood diseases. Pediatric Nephrology 5 th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1179-1197 (2004)
76. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988)
77. Lee YC, Cheon KT, Lee HB, Kim W, Rhee YK, Kim DS: Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy 55, 959-963 (2000)
78. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM Jr, Bruckner UB: Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1(2), 177-189 (1997)
79. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Chen Y, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K, Miki T: Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens. Res. 26(7), 547-552 (2003)